1. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999; 25:103–119.
Article
2. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49:759–772.
Article
3. Kremer S, Abu Eid M, Bierry G, et al. Accuracy of delayed postcontrast FLAIR MR imaging for the diagnosis of leptomeningeal infectious or tumoral diseases. J Neuroradiol. 2006; 33:285–291.
Article
4. Misaki K, Nakada M, Hayashi Y, et al. Contrast-enhanced fluid-attenuated inversion recovery MRI is useful to detect the CSF dissemination of glioblastoma. J Comput Assist Tomogr. 2001; 25:953–956.
Article
5. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology. 1999; 211:257–263.
Article
6. Terae S, Yoshida D, Kudo K, Tha KK, Fujino M, Miyasaka K. Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: usefulness in the evaluation of brain metastases. J Magn Reson Imaging. 2007; 25:479–487.
Article
7. Fukuoka H, Hirai T, Okuda T, et al. Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. AJNR Am J Neuroradiol. 2010; 31:868–873.
Article
8. Tomura N, Narita K, Takahashi S, et al. Contrast-enhanced multi-shot echoplanar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging. Acta Radiol. 2007; 48:1032–1037.
Article
9. Jackson EF, Hayman LA. Meningeal enhancement on fast FLAIR images. Radiology. 2000; 215:922–924.
Article
10. Park J, Kim J, Yoo E, Lee H, Chang JH, Kim EY. Detection of small metastatic brain tumors: comparison of 3D contrast-enhanced whole-brain black-blood imaging and MP-RAGE imaging. Invest Radiol. 2012; 47:136–141.
11. Kammer NN, Coppenrath E, Treitl KM, Kooijman H, Dietrich O, Saam T. Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours. Eur Radiol. 2016; 26:1818–1825.
Article
12. Park J, Kim EY. Contrast-enhanced, three-dimensional, whole-brain, black-blood imaging: application to small brain metastases. Magn Reson Med. 2010; 63:553–561.
Article
13. Korosec FR, Grist TM, Polzin JA, Weber DM, Mistretta CA. MR angiography using velocity-selective preparation pulses and segmented gradient-echo acquisition. Magn Reson Med. 1993; 30:704–714.
Article
14. Norris DG, Schwarzbauer C. Velocity selective radiofrequency pulse trains. J Magn Reson. 1999; 137:231–236.
Article
15. Nagao E, Yoshiura T, Hiwatashi A, et al. 3D turbo spin-echo sequence with motion-sensitized driven-equilibrium preparation for detection of brain metastases on 3T MR imaging. AJNR Am J Neuroradiol. 2011; 32:664–670.
Article
16. Busse RF, Brau AC, Vu A, et al. Effects of refocusing flip angle modulation and view ordering in 3D fast spin echo. Magn Reson Med. 2008; 60:640–649.
Article
17. Takemoto K, Takano K, Abe H, et al. The new MRI modalities "BPAS and VISTA" for the diagnosis of VA dissection. Acta Neurochir Suppl. 2011; 112:59–65.
Article
18. Kato Y, Higano S, Tamura H, et al. Usefulness of contrast-enhanced T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolutions in detection of small brain metastasis at 3T MR imaging: comparison with magnetization-prepared rapid acquisition of gradient echo imaging. AJNR Am J Neuroradiol. 2009; 30:923–929.
Article
19. Collie DA, Brush JP, Lammie GA, et al. Imaging features of leptomeningeal metastases. Clin Radiol. 1999; 54:765–771.
Article
20. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995; 38:51–57.
Article
21. Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol. 1999; 246:810–814.
Article
22. Ahn SJ, Suh SH, Lee KY, Kim JH, Seo KD, Lee S. Hyperintense vessels on T2-PROPELLER-FLAIR in patients with acute MCA stroke: prediction of arterial stenosis and perfusion abnormality. AJNR Am J Neuroradiol. 2015; 36:2042–2047.
Article
23. Ahn SJ, Lee KY, Ahn SS, Suh H, Kim BS, Lee SK. Can FLAIR hyperintense vessel (FHV) signs be influenced by varying MR parameters and flow velocities? A flow phantom analysis. Acta Radiol. 2016; 57:580–586.
Article
24. Ahn SJ, Chung TS, Chang JH, Lee SK. The added value of double dose gadolinium enhanced 3D T2 fluid-attenuated inversion recovery for evaluating small brain metastases. Yonsei Med J. 2014; 55:1231–1237.
Article
25. Jeong HK, Oh SW, Kim J, Lee SK, Ahn SJ. Reduction of oxygen-induced CSF hyperintensity on FLAIR MR images in sedated children: usefulness of magnetization-prepared FLAIR imaging. AJNR Am J Neuroradiol. 2016; 37:1549–1555.
Article
26. Siegal T, Sandbank U, Gabizon A, et al. Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study. J Neurooncol. 1987; 4:233–242.
27. Ludemann L, Grieger W, Wurm R, Wust P, Zimmer C. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging. 2005; 23:833–841.
28. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol. 2006; 41:213–221.
Article
29. van der Molen AJ, Bellin MF. Extracellular gadolinium-based contrast media: differences in diagnostic efficacy. Eur J Radiol. 2008; 66:168–174.
Article
30. Ruff RL, Dougherty JH Jr. Complications of lumbar puncture followed by anticoagulation. Stroke. 1981; 12:879–881.
Article
31. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010; 74:1449–1454.
Article
32. Glass JP, Melamed M, Chernik NL, Posner JB. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979; 29:1369–1375.
Article